Healthpeak Properties (NYSE:DOC) Upgraded to Outperform at Raymond James Financial

Key Points

• Healthpeak Properties has been upgraded to an "outperform" rating by Raymond James Financial, with a target price of $20.00, indicating a potential upside of 10.47% from its previous close.
• Despite the upgrade, other analysts have mixed views, with Deutsche Bank lowering its price target from $28.00 to $18.00 and Scotiabank downgrading the stock from "sector outperform" to "sector perform."
• Healthpeak reported earnings per share of $0.46, meeting analysts' expectations, but their revenue declined by 0.2% compared to last year.

Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by stock analysts at Raymond James Financial from a "market perform" rating to an "outperform" rating in a report released on Monday, MarketBeat Ratings reports. The brokerage presently has a $20.00 target price on the real estate investment trust's stock. Raymond James Financial's price target would suggest a potential upside of 10.47% from the stock's previous close.

Other research analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Morgan Stanley dropped their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Scotiabank lowered shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price objective for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 27th. Finally, Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $21.36.

Healthpeak Properties Trading Down 0.2%

DOC stock opened at $18.10 on Monday. The firm has a fifty day moving average price of $17.76 and a 200 day moving average price of $18.17. Healthpeak Properties has a fifty-two week low of $16.63 and a fifty-two week high of $23.26. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The firm has a market cap of $12.58 billion, a PE ratio of 75.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.07.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same period last year, the firm posted $0.45 earnings per share. Healthpeak Properties's revenue for the quarter was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Scott M. Brinker bought 1,490 shares of the stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $16.83 per share, with a total value of $25,076.70. Following the completion of the purchase, the chief executive officer owned 211,906 shares of the company's stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have acquired 8,783 shares of company stock worth $150,129 over the last ninety days. 0.23% of the stock is currently owned by insiders.

Institutional Trading of Healthpeak Properties

A number of large investors have recently made changes to their positions in DOC. Janus Henderson Group PLC boosted its stake in shares of Healthpeak Properties by 2.1% during the fourth quarter. Janus Henderson Group PLC now owns 79,403 shares of the real estate investment trust's stock valued at $1,611,000 after purchasing an additional 1,603 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Healthpeak Properties by 9.3% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,951 shares of the real estate investment trust's stock valued at $1,175,000 after acquiring an additional 4,920 shares in the last quarter. ProShare Advisors LLC raised its holdings in shares of Healthpeak Properties by 29.8% in the fourth quarter. ProShare Advisors LLC now owns 176,001 shares of the real estate investment trust's stock valued at $3,568,000 after acquiring an additional 40,432 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Healthpeak Properties by 197.3% in the fourth quarter. Point72 Asset Management L.P. now owns 352,339 shares of the real estate investment trust's stock valued at $7,142,000 after acquiring an additional 233,839 shares in the last quarter. Finally, Royal Bank of Canada raised its holdings in shares of Healthpeak Properties by 52.5% in the fourth quarter. Royal Bank of Canada now owns 1,080,999 shares of the real estate investment trust's stock valued at $21,913,000 after acquiring an additional 372,324 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.